|
|
Effect of Yangyin Yifei Decoction on Serum NO,VEGF Levels and KPS Scores in Patients With Non-Small Cell Lung Cancer |
Shen Qixin, Zhou Dongdong, Liu Jie |
Department of Oncology,Zhumadian Traditional Chinese Medicine Hospital,Zhumadian 463000,Henan |
|
|
Abstract Objective To investigate the effect of Yangyin Yifei Decoction on serum nitric oxide(NO),vascular endothelial growth factor(VEGF)levels and KPS in patients with non-small cell lung cancer. Methods The clinical data of 60 patients with non-small cell carcinoma treated were retrospectively analyzed.31 patients treated with GP chemotherapy combined with Yangyin Yifei Decoction were included in the observation group.29 patients treated with GP chemotherapy were included in the control group.3 weeks was a course of treatment,and both groups were treated continuously for 2 courses.The KPS score,serum NO and VEGF levels,and the recurrence rate within 1 year were compared between the two groups. Results After 6 weeks of treatment,the KPS score and NO level of the observation group were higher than that of the control group,the VEGF level was lower than that of the control group,and the recurrence rate of the observation group within 1 year was lower than that of the control group.The difference was statistically significant(P<0.05). Conclusion Yangyin Yifei Decoction can improve serum NO level and reduce blood VEGF concentration in patients with non-small cell lung cancer,and it has a significant effect in promoting patient recovery and improving prognosis.
|
Received: 12 September 2020
|
|
|
|
|
[1] 何艳玲,涂红缨.miRNA与非小细胞肺癌诊治相关性的研究进展[J].山东医药,2017,57(4):110-112. [2] 曹敏敏. GP方案化疗联合手术治疗Ⅲ期非小细胞肺癌临床疗效研究[J].现代诊断与治疗,2016,27(6):1142-1143. [3] 蔡静,候玥.非小细胞肺癌患者血清miR-195的表达及其临床意义[J].实用肿瘤学杂志,2018,32(5):415-419. [4] 梁惠,喻怀斌,李要轩,等.益气养阴汤联合厄洛替尼治疗中晚期肺腺癌临床研究[J].安徽中医药大学学报,2019,38(5):41-44. [5] 李德辉,孙春霞,范焕芳.六君子汤加减辅助晚期非小细胞肺癌化疗的临床观察[J].中国药房,2017,28(36):5068-5071. [6] 孙燕,周际昌.临床肿瘤内科手册(第三版)[M].北京:人民卫生出版社,2008:462. [7] 中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:74-234. [8] 李群,徐鹏,熊明.中西医结合治疗对非小细胞肺癌患者疗效、毒副作用及KPS评分的影响[J].现代中西医结合杂志,2019,28(9):991-993. [9] 常青. 晚期非鳞非小细胞肺癌患者化疗疗效、缓解深度与无进展生存期的相关性[J].肿瘤学杂志,2019,25(9):793-797. |
[1] |
. [J]. journal1, 2021, 41(6): 67-68. |
[2] |
. [J]. journal1, 2021, 41(6): 72-73. |
[3] |
. [J]. journal1, 2021, 41(4): 102-103. |
[4] |
. [J]. journal1, 2021, 41(1): 51-52. |
|
|
|
|